May 13, 2014 / 12:17 PM / 4 years ago

Valeant says plans to "improve" offer for Allergan

May 13 (Reuters) - Valeant Pharmaceuticals International Inc said it planned to “improve” its $47 billion takeover offer for drugmaker Allergan Inc, a day after the U.S. company rejected the bid.

Canada’s Valeant said it remained committed to getting the deal done but would remain “financially disciplined.”

Allergan, which makes the popular anti-wrinkle treatment Botox, said on Monday that Valeant’s business model was unsustainable and the offer was too risky because of uncertainty about the company’s long-term growth. (Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below